All Carlos Acuna-Villaorduna articles
-
NewsStudy demonstrates efficacy of new short-term resistant TB treatment
Four patients at Boston Medical Center (BMC) Tuberculosis Clinic were cured of MDR TB with a six-month regimen that included bedaquiline, pretomanid and linezolid (BPaL).
